of HIV, for example, are high among people with schizophrenia, 34 yet nurses' adherence to aspects of universal precautions for infection control, specifically glove-wearing, is generally poor. 35 Having explored the technical aspects of LAIs we need to consider the clinical skills and techniques that clinicians can use to have conversations with patients about starting, switching and sticking to LAIs. `Power questions', exchanging information, monitoring the effects of treatment and enabling patients to make choices in advance are medication management skills that facilitate shared decision-making (see Appendix 1). Use of `power questions' We have already established that patients do not perceive that they are involved in treatment decisions. 14 What can patients and carers do to help them take control and enable them to consider whether an LAI is a choice that might suit them? Patients and carers can take personal responsibility in ensuring that they are involved in treatment decisions by making use of `power questions'. 36 These are essential and focused questions that patients and carers can ask during a meeting with health professionals. Having a list of set questions will ensure that the patient and carer acquire the information that they need to help them make choices about treatment. Practitioners need to provide clear, factual information to patients in response to the questions they are asked. When talking about LAIs, it is important to talk about the theoretical benefits as well as the lack of compelling evidence that these are translated into better outcomes for patients. Some